Prostaglandin E1 and arterial occlusive disease: pharmacological considerations.
Simmet
T
T
Institute of Pharmacology and Toxicology, Ruhr-University of Bochum, FRG.
Peskar
B A
BA
D000527:Alprostadil / Q000096:biosynthesis / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology*; D001157:Arterial Occlusive Diseases / Q000503:physiopathology*; D006801:Humans
D000527:Alprostadil